Candiduria: Prevalence and trends in antifungal susceptibility in a tertiary care hospital of Mangalore

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 11, 2013, Pages 2459-2461

  Yashavanth, Rai ^a   Shiju, M P ^b   Bhaskar, U A ^a   Ronald, R ^a   Anita, K B ^a  

^a A J INSTITUTE OF MEDICAL SCIENCES   (India)

^b Department of Gastroenterology and Liver Disease   (India)

Author keywords

Antifungal susceptibility testing; Candiduria; Non albicans Candida

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; VORICONAZOLE;

ANALYTICAL EQUIPMENT; ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDURIA; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; FUNGAL COLONIZATION; FUNGUS GROWTH; FUNGUS ISOLATION; HUMAN; INDIA; MALE; NONHUMAN; PREVALENCE; TREND STUDY; URINALYSIS;

EID: 84887333963     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/6298.3578     Document Type: Article

References (20)

1. Manisha J, Vinita D, Bibhabati M, Archana T, Poonam SL, Aradhana B. Candiduria in catheterized intensive care unit patients: Emerging microbiological trends. Ind. J. Path. Micro. 2011; 54(3): 552-55.
2. Pfaller MA, Diekema DJ, Messer SA, Boyken L and Hollis RJ. Activities of fluconazole and voriconazole against 1,586 recent clinical isolate of Candida species determined by broth microdilution, disc diffusion and E test method: report from the ARTEMIS global antifungal susceptibility program 2001. J Clin Microbiol. 2003; 41:1440-46.
3. Lundstrom T, Sobel J. Nosocomial candiduria: A review. Clin Infect Dis. 2001; 32:1602-07.
4. Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW, et al. Prospective multicenter surveillance study of funguria in hospitalised patients. Clin Infect Dis. 2000; 30:14-18.
5. Manjunath GN, Prakash R, Vamseedhar A, Kiran S. Changing trends in the spectrum of antimicrobial drug resistance pattern of uropathogens isolated from hospitals and community patients with urinary tract infections in Tumkur and Bangalore. Int J Biol Med Res. 2011; 2(2):504-07
6. Ang BSP, Talenti A, King B, Steekelberg JM, Wilson WR. Candidaemia from a urinary tract source: Microbiological aspects and clinical significance. Clin Infect Dis. 1993; 17 (4): 626-66.
7. Chakrabarthi A, Mohan B, Shrivastava SK, Marak RSK, Ghosh A, Ray P. Change in the distribution and antifungal susceptibility of Candida species isolated from candidaemia cases in a tertiary care centre during 1996-2000. Ind. J. Med. Res. 2002; 116:5-12.
8. Lymn LH, Duane RH, Eliriton KM, Dooley D. Direct isolation of Candida spp from blood cultures on the chromogenic medium CHROM agar candida. J Clin Microbiol. 2003; 41:6:2629-32.
9. OddsFC and Bernaets R. CHROM agar Candida a new differential medium for presumptive identification of clinically important candida species. J Clin Microbial. 1994; 12:1923-129.
10. Latha R, Sasikala R, Muruganandam N, Venkatesh BR: Study on the shifting pattern of Non Candida albicans in lower respiratotry tract infections and evaluation of the CHROM agar in identification of Candida species. J Microbiol and Bio Res. 2001; (3):113-19.
11. Bourgeois N, Dehandschoewercker L, Bertout S, Bousquet PJ, Rispail P, Lachaud L. Antifungal Susceptibility of 205 Candida species isolated Primarily during invasive Candidiasis and Comparison of the Vitek 2 System with the CLSI Broth Microdilution and Etest Methods. J Clin Microbial. 2010; 48: 154-61.
12. Ochipinti DJ, Gubbins PO, Schreckenberger P, Danziger LH. Frequency pathogenicity and microbiologic outcome of non Candida albicans candiduria. Europ J Clin Microbiol Infect Dis. 1994; 13:459-67.
13. Hartstein AI, Garber SB, Ward TT, Jones SR and Morthland VH. Nosocomial urinary tract infection: a prospective evaluation of 108 catheterized patients. Infect. Control. 1981; 2:380-86
14. Annaissie E, Samonis G, Kontoyiannis D, Costerton J, Sabharwal U, Bodey G. et al. Role of catheter related infections. Eur J Clin Microbiol Infect Dis. 1995; 14: 135-37.
15. McLean RJC, Nickel JC, Olson ME. Biofilm associated urinary tract infections, In Microbial Biofilms. HM Lappin-Scott and JW costerton (ed); 1995: 261-73.
16. Achkar JM and Fries BC. Candida Infections of the Genitourinary Tracts. Clin Microbiol Rev. 2010 April;23(2): 253-73
17. Ragini AK, Sandhya B, Gayatri D, Indumati. Incidence of Non Candida albicans in patients with Urinary Tract Infection with special Reference to speciation and Antifungal Susceptibility. JEMDS. 2012; 1(4): 572-76.
18. Iman KB, Shorouk KEH, Muhmoud M. Candida infection associated with urinary catheter in critically ill patients. Identification, antifungal susceptibility and risk factors. Res.J. of Med & Med sciences. 2010; 5(1):79-86.
19. Prasad KN. Role of yeasts as nosocomial pathogens and their susceptibility to Fluconazole and Amphotericin. Ind. J. Med. Res. 1999; 110:11-17.
20. Shivanand D, Saldanha D. Species identification of Candida isolates in various clinical specimens with their antifungal susceptibility patterns. JCDR. 2011; 5(6): 1177-81.